Concepedia

Faisal Fa’ak

FF

12

Publications

966

Citations

12

H-Index

2016

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Assiut University Hospitals

University of Houston

Harvard University

Faisal Fa’ak is an author at The University of Texas MD Anderson Cancer Center specializing in tumor immunology, tumor immunity, and immunotherapy.

ORCID

Top concepts

Publications per year

2016–2023

12

Publications

12

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

Yared Hailemichael, Daniel H. Johnson, Noha Abdel‐Wahab et al. · Cancer Cell · 2022 · 314 citations · Full text

, , +5

Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy

Meenu Sharma, Hiep Khong, Faisal Fa’ak et al. · Nature Communications · 2020 · 163 citations · Full text

Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events

Faisal Fa’ak, Maryam Buni, Adewunmi Falohun et al. · Journal for ImmunoTherapy of Cancer · 2023 · 84 citations · Full text

Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain

Manisha Singh, Christina Vianden, Mark J. Cantwell et al. · Nature Communications · 2017 · 82 citations · Full text

Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy

Yared Hailemichael, Amber N. Woods, Tihui Fu et al. · Journal of Clinical Investigation · 2018 · 80 citations · Full text

Rows per page

1–5 of 12